Form 4 for BMRN BIOMARIN PHARMACEUTICAL INC
Accepted 2024-05-31 00:00:00 ET · period of report 2024-05-30 · accession 0001048477-24-000114 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-05-31 | 2024-04-30 | BMRN | Mueller Brian | EVP, CFO | A - Grant | $68.65 | +300 | 72.2K | +0.4% | +$20.6K |
| D | 2024-05-31 | 2024-05-30 | BMRN | Mueller Brian | EVP, CFO | S - Sale+OE | $75.19 | -5,000 | 72.2K | -6% | -$375.9K |
| D | 2024-05-31 | 2024-05-30 | BMRN | Mueller Brian | EVP, CFO | M - OptEx | $63.10 | +5,000 | 77.2K | +7% | +$315.5K |
| D | 2024-05-31 | 2024-05-30 | BMRN | Mueller Brian | EVP, CFO | M - OptEx | $0.00 | -5,000 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-04-30 | A | A | 300 | $68.65 | 72,159 | D | — | — | (F1) Represents the shares acquired by the reporting person on April 30, 2024, pursuant to the issuer's Employee Stock Purchase Plan. |
| 2 | Common | Common Stock | 2024-05-30 | S | D | 5,000 | $75.19 | 72,159 | D | — | — | (F2) Trade made pursuant to a 10b5-1 plan executed on August 18, 2023. |
| 3 | Common | Common Stock | 2024-05-30 | M | A | 5,000 | $63.10 | 77,159 | D | — | — | (F2) Trade made pursuant to a 10b5-1 plan executed on August 18, 2023. |
| 4 | Derivative | Stock Option (Right to Buy Common Stock) | 2024-05-30 | M | D | 5,000 | $0.00 | 0 | D | $63.10 · 2014-12-04 to 2024-06-03 | 5,000 Common Stock | (F3) Reflects the number of options outstanding after the transactions from this specific stock option grant. |